AstraZeneca's global headquarters is located in London, England. AstraZeneca was formed by the merger of Astra Company in Sweden and Jellicon Company in Britain on 1999. In China, AstraZeneca's business focuses on the treatment areas that China patients need most, including cardiovascular diseases, metabolic diseases, tumors, respiratory system, digestive system and kidney diseases.
Company development process
AstraZeneca has established Zhangjiang Hi-tech Park in China, where there are biopharmaceutical R&D centers, academic training and global functional departments. There are several business departments in the park, including the Medical Department and the Digital and Business Innovation Department.
In AstraZeneca Science Park, we are developing vigorously with diversified thinking. The park has created an advanced and environmentally-friendly architectural concept and an atmosphere of innovation and cooperation, making it an inspiring workplace and academic exchange center for customers.
AstraZeneca's strategy is to provide employees with opportunities to collaborate with each other, develop their innovative ability and share their views on the ever-changing environment by forming a regional management team (RMT).
Reference to the above content: Baidu Encyclopedia-AstraZeneca